Two functional domains of the influenza virus NS1 protein are required for regulation of nuclear export of mRNA

The influenza virus NS1 protein is the only known example of a protein that inhibits the nuclear export of mRNA. To identify the functional domains of this protein, we introduced 18 2- or 3-amino-acid substitutions at approximately equally spaced locations along the entire length of the protein. Two functional domains were identified. The domain near the amino end (amino acids 19 through 38) was shown to be the RNA-binding domain, by using a gel shift assay with purified NS1 protein and spliced viral NS2 mRNA as the RNA target. The second domain, which is in the carboxy half of the molecule, was presumed to be the effector domain that interacts with host nuclear proteins to carry out the nuclear RNA export function, by analogy with the effector domain of the Rev proteins of human immunodeficiency virus (HIV) and other lentiviruses which facilitate rather than inhibit nuclear RNA export. The NS1 protein has a 10-amino-acid sequence that is similar to the consensus sequence in the effector domains of lentivirus Rev proteins, specifically including two crucial leucines at positions 7 and 9 of this sequence. However, the effector domains of the NS1 and Rev (HIV type 1 [HIV-1]) proteins differed in several significant ways including the following: (i) unlike the HIV-1 Rev protein, NS1 effector domain mutants were negative recessive rather than negative dominant, (ii) the NS1 effector domain is about three times larger than the effector domain of the HIV-1 Rev protein, and (iii) unlike the HIV-1 protein, NS1 effector domain mutants exhibited a surprising property, a changed intracellular/intranuclear distribution, compared with the wild-type protein. These differences strongly suggest that the effector domains of the NS1 and Rev proteins interact with different nuclear protein targets, which likely explains the opposite effects of these two proteins on nuclear mRNA export.

[1]  P. Sharp,et al.  Specific regulation of mRNA splicing in vitro by a peptide from HIV-1 Rev , 1991, Cell.

[2]  D. Antelman,et al.  Purification and characterization of recombinant Rev protein of human immunodeficiency virus type 1. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[3]  D. McDonald,et al.  Effector domains of human immunodeficiency virus type 1 Rev and human T-cell leukemia virus type I Rex are functionally interchangeable and share an essential peptide motif , 1991, Journal of virology.

[4]  G. Pavlakis,et al.  The rev (trs/art) protein of human immunodeficiency virus type 1 affects viral mRNA and protein expression via a cis-acting sequence in the env region , 1989, Journal of virology.

[5]  S. Le,et al.  The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA , 1989, Nature.

[6]  W C Greene,et al.  Comparative analysis of the HTLV-I Rex and HIV-1 Rev trans-regulatory proteins and their RNA response elements. , 1989, Genes & development.

[7]  P. Palese,et al.  Expression of influenza virus NS2 nonstructural protein in bacteria and localization of NS2 in infected eucaryotic cells , 1985, Journal of virology.

[8]  M. Katze,et al.  Efficient transcription, not translation, is dependent on adenovirus tripartite leader sequences at late times of infection , 1988, Journal of virology.

[9]  T. Hope,et al.  trans-dominant inhibition of human immunodeficiency virus type 1 Rev occurs through formation of inactive protein complexes , 1992, Journal of virology.

[10]  M. Malim,et al.  Conserved functional organization of the human immunodeficiency virus type 1 and visna virus Rev proteins , 1991, Journal of virology.

[11]  M. Malim,et al.  HIV-1 structural gene expression requires the binding of multiple Rev monomers to the viral RRE: Implications for HIV-1 latency , 1991, Cell.

[12]  H. Olsen,et al.  Interaction of the human immunodeficiency virus type 1 Rev protein with a structured region in env mRNA is dependent on multimer formation mediated through a basic stretch of amino acids. , 1990, Genes & development.

[13]  E. Wahle.  A novel poly(A)-binding protein acts as a specificity factor in the second phase of messenger RNA polyadenylation , 1991, Cell.

[14]  T. Pieler,et al.  The Xenopus laevis poly(A) binding protein is composed of multiple functionally independent RNA binding domains. , 1990, The EMBO journal.

[15]  R. Krug,et al.  Cytoplasmic and nuclear virus-specific proteins in influenza virus-infected MDCK cells. , 1973, Virology.

[16]  P. Sharp,et al.  Regulation by HIV Rev depends upon recognition of splice sites , 1989, Cell.

[17]  T. Hope,et al.  Oligomerization and RNA binding domains of the type 1 human immunodeficiency virus Rev protein: a dual function for an arginine-rich binding motif. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[18]  R. Compans.  Influenza virus proteins. II. Association with components of the cytoplasm. , 1973, Virology.

[19]  M. Hammarskjöld,et al.  U1 small nuclear RNA plays a direct role in the formation of a rev-regulated human immunodeficiency virus env mRNA that remains unspliced. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[20]  P. Palese,et al.  Two nuclear location signals in the influenza virus NS1 nonstructural protein , 1988, Journal of virology.

[21]  M. Hammarskjöld,et al.  Regulation of human immunodeficiency virus env expression by the rev gene product , 1989, Journal of virology.

[22]  N. Sonenberg,et al.  A bulge structure in HIV-1 TAR RNA is required for Tat binding and Tat-mediated trans-activation. , 1990, Disease markers.

[23]  R. Krug,et al.  The influenza virus NS1 protein is a poly(A)-binding protein that inhibits nuclear export of mRNAs containing poly(A) , 1994, Journal of virology.

[24]  J. Keene,et al.  RNA recognition: towards identifying determinants of specificity. , 1991, Trends in biochemical sciences.

[25]  D. Reinberg,et al.  Regulation of RNA polymerase II transcription. , 1993, Current opinion in cell biology.

[26]  D. McDonald,et al.  Posttranscriptional regulation by the human immunodeficiency virus type 1 Rev and human T-cell leukemia virus type I Rex proteins through a heterologous RNA binding site , 1992, Journal of virology.

[27]  T. Copeland,et al.  rev protein of human immunodeficiency virus type 1 affects the stability and transport of the viral mRNA. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[28]  R. Krug,et al.  Nucleocytoplasmic transport: the influenza virus NS1 protein regulates the transport of spliced NS2 mRNA and its precursor NS1 mRNA. , 1992, Genes & development.

[29]  D. Lazinski,et al.  Sequence-specific recognition of RNA hairpins by bacteriophage antiterminators requires a conserved arginine-rich motif , 1989, Cell.

[30]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[31]  M. Malim,et al.  Mutational definition of the human immunodeficiency virus type 1 Rev activation domain , 1991, Journal of virology.

[32]  S. Holland,et al.  Human immunodeficiency virus type 1 Rev activation can be achieved without Rev-responsive element RNA if Rev is directed to the target as a Rev/MS2 fusion protein which tethers the MS2 operator RNA , 1992, Journal of virology.

[33]  M. Malim,et al.  Functional dissection of the HIV-1 Rev trans-activator—Derivation of a trans-dominant repressor of Rev function , 1989, Cell.